Georges Rawadi holds a Ph.D. in Microbiology from the University of Paris VI (Pierre et Marie Curie) and completed advanced training in business and management at ESSEC Business School. With over 25 years in the pharma and biotech sectors, Georges has worked across a range of roles, from scientific research and drug discovery to business development, executive leadership, and entrepreneurship, helping biotechnology companies to build cutting-edge pipelines and strategies. Currently, Georges is the CEO of StromaCare and serves as a board member and consultant to various biotech companies. Previously, he was CEO of Celyad Oncology, a company listed on Euronext, and of YSOPIA Bioscience. He also held the role of Chief of Biotech Studio Development at EureKare and served as Vice President of Business Development & Intellectual Property at Celyad and Cellectis. Georges has also excelled in senior business development roles at Galapagos, ProStrakan and has led numerous consulting projects focused on strategic development. Georges’ extensive experience uniquely positions him to drive innovation and strategic growth in the biotech industry.